| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Fabienne Brilot | Q88233665 |
| P2093 | author name string | Russell C Dale | |
| Deepti Pilli | |||
| Fiona Tea | |||
| Alicia Zou | |||
| P2860 | cites work | Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 |
| Environmental risk factors for multiple sclerosis. Part I: The role of infection | Q22252937 | ||
| Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” | Q22252938 | ||
| Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis | Q24620536 | ||
| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis | Q24635370 | ||
| Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies | Q24642126 | ||
| Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain | Q24642187 | ||
| CNS immune privilege: hiding in plain sight | Q24642697 | ||
| IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel | Q24646531 | ||
| T cell response to Hu-D peptides in patients with anti-Hu syndrome | Q24654675 | ||
| Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis | Q24681662 | ||
| Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human disease | Q24806258 | ||
| Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms | Q26795528 | ||
| B Cells and Autoantibodies in Multiple Sclerosis | Q26801386 | ||
| A brief history of T cell help to B cells | Q26825185 | ||
| Autoimmune encephalitis update | Q26827114 | ||
| Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms | Q27006941 | ||
| A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules | Q27308814 | ||
| Structural and functional features of central nervous system lymphatic vessels | Q27316769 | ||
| Deconstructing the Peptide-MHC Specificity of T Cell Recognition | Q27683914 | ||
| Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population | Q85067588 | ||
| Paraneoplastic neurological syndromes | Q87240628 | ||
| T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching | Q36400665 | ||
| Multiple sclerosis--the plaque and its pathogenesis | Q36410882 | ||
| Paraneoplastic syndromes of the CNS. | Q36631871 | ||
| Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid. | Q36646146 | ||
| Induction of MHC class I genes in neurons | Q36688665 | ||
| Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system | Q36812520 | ||
| CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. | Q36899833 | ||
| Multiple sclerosis: a complicated picture of autoimmunity. | Q36915907 | ||
| Antibody to aquaporin-4 in the long-term course of neuromyelitis optica | Q36961015 | ||
| T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. | Q36968498 | ||
| Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis | Q36975877 | ||
| IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells | Q36985100 | ||
| CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation | Q37149908 | ||
| The genetics of multiple sclerosis and its experimental models | Q37152679 | ||
| Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function | Q37180600 | ||
| Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells | Q37378116 | ||
| Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis | Q37481523 | ||
| CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability | Q37536463 | ||
| Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma | Q37555169 | ||
| Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? | Q37778944 | ||
| Cytokines and effector T cell subsets causing autoimmune CNS disease | Q37863274 | ||
| Multiple sclerosis: new insights in pathogenesis and novel therapeutics. | Q37925826 | ||
| Paraneoplastic encephalomyelopathies: pathology and mechanisms | Q37936924 | ||
| Molecular mimicry as a mechanism of autoimmune disease | Q37957762 | ||
| Pathogenic CD8 T cells in multiple sclerosis and its experimental models | Q38008365 | ||
| The anatomical and cellular basis of immune surveillance in the central nervous system. | Q38035711 | ||
| Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities | Q38097385 | ||
| Flow-cytometric analysis of rare antigen-specific T cells | Q38115990 | ||
| Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system. | Q38162307 | ||
| Autoimmune encephalitis: recent updates and emerging challenges. | Q38163725 | ||
| Environmental factors in multiple sclerosis | Q38167388 | ||
| Th17 cells in central nervous system autoimmunity | Q38200386 | ||
| T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases | Q38274179 | ||
| Role of the innate and adaptive immune responses in the course of multiple sclerosis | Q38384621 | ||
| Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study. | Q38409715 | ||
| Subpial demyelination in the cerebral cortex of multiple sclerosis patients | Q48233815 | ||
| Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. | Q48301180 | ||
| Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions | Q48338419 | ||
| Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis | Q48475017 | ||
| Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis | Q48545839 | ||
| Inducible expression of H-2 and Ia antigens on brain cells | Q48633246 | ||
| Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis | Q48638151 | ||
| Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells | Q48660181 | ||
| Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis | Q48709950 | ||
| Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders | Q48771858 | ||
| Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions | Q48791086 | ||
| Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. | Q48853057 | ||
| Stiff, twitchy or wobbly: are GAD antibodies pathogenic? | Q48921988 | ||
| Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration | Q48949272 | ||
| Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients | Q49029367 | ||
| Rasmussen encephalitis treated with natalizumab. | Q50883512 | ||
| Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. | Q51000334 | ||
| Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. | Q51354602 | ||
| Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis. | Q38412781 | ||
| IL-6 as a keystone cytokine in health and disease | Q38433045 | ||
| Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry | Q38530339 | ||
| Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination | Q38680651 | ||
| T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO). | Q38779424 | ||
| Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis | Q38815944 | ||
| Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis | Q38958215 | ||
| NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture | Q39030050 | ||
| T cell-activation in neuromyelitis optica lesions plays a role in their formation. | Q39039987 | ||
| Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis | Q39110932 | ||
| Antigen-reactive T cell enrichment for direct, high-resolution analysis of the human naive and memory Th cell repertoire | Q39182538 | ||
| Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis | Q39499696 | ||
| Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. | Q39770767 | ||
| Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome | Q39913279 | ||
| Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis | Q39961545 | ||
| Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis | Q40569666 | ||
| Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis. | Q40581562 | ||
| Research Techniques Made Simple: Monitoring of T-Cell Subsets using the ELISPOT Assay. | Q40663996 | ||
| Follicular Helper T Cells | Q40780566 | ||
| Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. | Q40869638 | ||
| Population attributable fractions and joint effects of key risk factors for multiple sclerosis | Q41096511 | ||
| PML: The Dark Side of Immunotherapy in Multiple Sclerosis | Q41190049 | ||
| Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients | Q41672999 | ||
| Simple Laboratory methods to measure cell proliferation using DNA synthesis property | Q41902526 | ||
| Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis | Q42463447 | ||
| CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery | Q42610657 | ||
| Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis | Q43076381 | ||
| Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis | Q43076400 | ||
| GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. | Q43775117 | ||
| Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis. | Q43919831 | ||
| Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures | Q44233555 | ||
| Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients | Q44234056 | ||
| Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins | Q44414983 | ||
| Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica | Q44425081 | ||
| A sensitive method for detecting proliferation of rare autoantigen-specific human T cells | Q44682968 | ||
| Is neuromyelitis optica associated with human leukocyte antigen? | Q44965114 | ||
| Association between clinical disease activity and Epstein-Barr virus reactivation in MS. | Q45741410 | ||
| A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF. | Q45845288 | ||
| High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). | Q45918488 | ||
| T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. | Q45993143 | ||
| Ligand recognition by alpha beta T cell receptors | Q46222293 | ||
| Brain gamma-aminobutyric acid changes in stiff-person syndrome | Q46547039 | ||
| Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients | Q46815045 | ||
| Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome | Q47671744 | ||
| Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis | Q48166222 | ||
| CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection | Q48213916 | ||
| Interleukin-6 and oligoclonal IgG synthesis in children with acute disseminated encephalomyelitis | Q48229881 | ||
| Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system | Q28075974 | ||
| Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration | Q28142447 | ||
| Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring | Q28243804 | ||
| A molecular trio in relapse and remission in multiple sclerosis | Q28245076 | ||
| Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis | Q28245345 | ||
| A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset | Q28247127 | ||
| Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis | Q28252596 | ||
| Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy | Q28284465 | ||
| Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses | Q28289228 | ||
| Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 | ||
| The spectrum of MOG autoantibody-associated demyelinating diseases | Q28293355 | ||
| The immunopathology of multiple sclerosis: an overview | Q28295115 | ||
| Multiple sclerosis | Q28299151 | ||
| Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders | Q28306660 | ||
| IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 | ||
| Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
| Risk alleles for multiple sclerosis identified by a genomewide study | Q29614890 | ||
| A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis | Q29615952 | ||
| A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis | Q29616119 | ||
| Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis | Q29620481 | ||
| Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis | Q30240138 | ||
| Understanding the Role of T Cells in CNS Homeostasis | Q30277739 | ||
| alpha4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions | Q30488236 | ||
| Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. | Q30741122 | ||
| Multiple sclerosis: T-cell receptor expression in distinct brain regions | Q33300045 | ||
| Autoimmune T cell responses in the central nervous system | Q33620003 | ||
| A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica | Q33727402 | ||
| Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies | Q33735202 | ||
| Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. | Q33842739 | ||
| Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis | Q33862720 | ||
| N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes | Q33882739 | ||
| Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes | Q33884262 | ||
| Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition | Q35947819 | ||
| The role of CD8(+) T cells in multiple sclerosis and its animal models | Q36107655 | ||
| Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis | Q36117017 | ||
| Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter | Q36117107 | ||
| Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? | Q36173589 | ||
| Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein | Q36194449 | ||
| Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain | Q36229219 | ||
| Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. | Q36318504 | ||
| Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis | Q36362874 | ||
| Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction | Q36368672 | ||
| Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. | Q51754875 | ||
| The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients. | Q51790592 | ||
| CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. | Q51982590 | ||
| Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. | Q52035328 | ||
| Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. | Q52047868 | ||
| Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. | Q52050849 | ||
| Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. | Q52936537 | ||
| Humoral and Cellular Autoimmune Responses in Stiff Person Syndrome | Q52956428 | ||
| Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome | Q53302766 | ||
| Immune surveillance in multiple sclerosis patients treated with natalizumab. | Q54606407 | ||
| Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. | Q55034045 | ||
| Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. | Q55239353 | ||
| Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6 | Q56771952 | ||
| Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis | Q56772014 | ||
| Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation | Q56907887 | ||
| HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis | Q58851197 | ||
| Brain immunohistopathological study in a patient with anti-NMDAR encephalitis | Q59697804 | ||
| Immunopathology of multiple sclerosis | Q63285399 | ||
| Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies | Q67486812 | ||
| The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course | Q69404589 | ||
| HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibody | Q71396044 | ||
| Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies | Q71876984 | ||
| Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function | Q72527023 | ||
| Association of HLA-DQB1*0201 with stiff-man syndrome | Q72662228 | ||
| The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells | Q72768300 | ||
| Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions | Q72773066 | ||
| Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation | Q72989725 | ||
| Increased peripheral blood interferon gamma-producing T cells in acute disseminated encephalomyelitis | Q73153774 | ||
| Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors | Q73726050 | ||
| Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment | Q73822011 | ||
| Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation | Q73822019 | ||
| Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy | Q73986186 | ||
| Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies | Q74395832 | ||
| T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity | Q74666138 | ||
| High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay | Q76376758 | ||
| Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis | Q77659285 | ||
| GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient | Q77756392 | ||
| Differential T cell response in central and peripheral nerve injury: connection with immune privilege | Q77933394 | ||
| Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis | Q78032106 | ||
| Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis | Q78074901 | ||
| Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis | Q79753191 | ||
| Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma | Q81124573 | ||
| Immunology of multiple sclerosis | Q81531267 | ||
| T-cell subsets and interleukin-6 response in Rasmussen's encephalitis | Q81720650 | ||
| Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease | Q82336392 | ||
| HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese | Q82732879 | ||
| Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells | Q83061199 | ||
| HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes | Q84403461 | ||
| Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse | Q84602582 | ||
| Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients | Q33890993 | ||
| Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients | Q33907001 | ||
| Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma | Q33925264 | ||
| Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus | Q34172103 | ||
| Focal seizures due to chronic localized encephalitis | Q34244319 | ||
| Vitamin D intake and incidence of multiple sclerosis | Q34289402 | ||
| Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis | Q34332988 | ||
| Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. | Q34368609 | ||
| Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement | Q34390601 | ||
| Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. | Q34479121 | ||
| CD8(+) T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing. | Q34520675 | ||
| Revised diagnostic criteria for neuromyelitis optica | Q34529345 | ||
| Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis | Q34573482 | ||
| Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis | Q34641782 | ||
| Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation | Q34683399 | ||
| Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. | Q34710256 | ||
| Gray matter atrophy in multiple sclerosis: a longitudinal study | Q34801849 | ||
| Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients | Q34823634 | ||
| Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice | Q34842262 | ||
| Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis | Q34963755 | ||
| Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. | Q35144356 | ||
| Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. | Q35168188 | ||
| Three or more routes for leukocyte migration into the central nervous system | Q35183162 | ||
| Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica | Q35234452 | ||
| Neuroimmunology: an expanding frontier in autoimmunity | Q35550781 | ||
| T cell subsets and their signature cytokines in autoimmune and inflammatory diseases | Q35558638 | ||
| Induction of Th17 cells by segmented filamentous bacteria in the murine intestine. | Q35598665 | ||
| T-cell-B-cell cooperation | Q35730842 | ||
| Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders | Q35753620 | ||
| Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine. | Q35783845 | ||
| Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities | Q35850673 | ||
| Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides | Q35882228 | ||
| B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination. | Q35937581 | ||
| P304 | page(s) | 652 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System | |
| P478 | volume | 8 |
| Q64246919 | A Pilot Study Identifying Brain-Targeting Adaptive Immunity in Pediatric Extracorporeal Membrane Oxygenation Patients With Acquired Brain Injury |
| Q89769616 | Antibody-Negative Paraneoplastic Limbic Encephalitis, Parkinsonism, Hypothermia, and Narcolepsy Associated with Endometrial Carcinoma |
| Q99565583 | Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P1) Modulators: Optimization of the PK, PD, and Safety Profiles |
| Q54217096 | Autoimmune phenotypes in schizophrenia reveal novel treatment targets. |
| Q91775838 | Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors |
| Q94450950 | COVID-19: ICU delirium management during SARS-CoV-2 pandemic |
| Q99239760 | Delirium in Older People with COVID-19: Clinical Scenario and Literature Review |
| Q95642664 | Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis |
| Q55228857 | Effect of photobiomodulation treatment in the sublingual, radial artery region, and along the spinal column in individuals with multiple sclerosis: Protocol for a randomized, controlled, double-blind, clinical trial. |
| Q92810672 | Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy |
| Q90265856 | Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle? |
| Q90452195 | Interleukin-1 Beta-A Friend or Foe in Malignancies? |
| Q92407350 | Neuronal Antibodies and Associated Syndromes |
| Q88773648 | T cells and Parkinson's disease |
| Q98513575 | T-cells produce acidic niches in lymph nodes to suppress their own effector functions |
| Q92094093 | α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease |
Search more.